New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
19:15 EDTRRD, HRG, TELK, ENDP, SAMOn The Fly: After Hours Movers
UP AFTER GUIDANCE: Boston Beer (SAM), up 12% after raising FY12 EPS view... ALSO HIGHER: Telik (TELK), up 28% after reporting preliminary clinical trial abstract for neutrophina treatment... R.R. Donnelley (RRD), up 3% after first day of trading on the S&P MidCap 400... DOWN AFTER GUIDANCE: Endo Health (ENDP), down 6% after cutting FY12, FY13 EPS views, announcing CEO to retire... ALSO LOWER: Harbiner Group (HRG), down 12% after filing to sell unknown amount of common stock.
News For SAM;TELK;RRD;ENDP;HRG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
09:11 EDTENDPEndo price target raised to $90 from $77 at Sterne Agee
Subscribe for More Information
December 18, 2014
05:32 EDTSAMBoston Beer initiated with a Buy at Nomura
Subscribe for More Information
December 16, 2014
08:58 EDTENDPEndo a top pick for 2015, says Sterne Agee
Subscribe for More Information
08:32 EDTSAM, SAMBoston Beer upgraded to Buy from Outperform at CLSA
Subscribe for More Information
December 11, 2014
17:04 EDTENDPEndo registration statement relating to Auxilium declared effective by SEC
Subscribe for More Information
10:13 EDTRRDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:28 EDTRRDR.R. Donnelley initiated with an Outperform at Macquarie
Target $22.
December 9, 2014
07:08 EDTENDPEndo completes acquisition of rights to Natesto from Trimel BioPharma
Endo International announced the completion of the acquisition of rights to Natesto, a testosterone nasal gel, the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma, a wholly-owned subsidiary of Trimel Pharmaceuticals for $25M including additional payments upon the achievement of certain regulatory and sales milestones. Endo will collaborate with Trimel on all regulatory and clinical development activities regarding Natesto. Endo intends to launch the product, through its Endo Pharmaceuticals subsidiary, in the Q1 of 2015.
December 8, 2014
09:32 EDTENDPSyneron Medical signs agreement with AMS to supply holmium laser for urology
Subscribe for More Information
December 7, 2014
17:43 EDTHRGRadioShack looks to amend terms of loan from Salus, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use